Neurobiology of Sensory Phenomena in Obsessive-Compulsive Disorder
NCT ID: NCT03451409
Last Updated: 2024-07-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
308 participants
OBSERVATIONAL
2018-05-05
2024-01-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This project builds on our preliminary data to (1) investigate the neural mechanisms of SP in large OCD cohort showing the full range of SP severity and (2) probe for familial risk markers in unaffected siblings of patients. For Aim 1, SP will be measured in 100 OCD patients using the Sensory Phenomena Scale. Diffusion and fMRI data will be acquired during rest and fMRI tasks. In order to identify familial risk markers, Aim 2 will compare sensory phenomena and neural circuitry between OCD probands, 50 unaffected biological siblings of OCD patients, and 50 unrelated healthy controls without a family history of Axis 1 disorders.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neurocircuit Mechanisms of OCD Across the Lifespan
NCT02437773
Neural Correlates of Compulsivity
NCT05195476
Neurofeedback for Treatment-resistant Obsessive-compulsive Disorder (OCD)
NCT03956771
Improving Obsessive-compulsive Disorder Treatments: from Lesions to Neuromodulation Targets
NCT06490965
Arbitration Between Habitual and Goal-directed Behavior in Obsessive-compulsive Disorder: Circuit Dynamics and Effects of Noninvasive Neurostimulation
NCT04075890
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
OCD Proband
Healthy controls (HC, n=50) without a family history of OCD will be matched to SIB.
Tasked based functional MRI (fMRI)
2-3 brief computer tasks while brain activity is being measured. The tasks performed will involve making button press responses to letters, numbers or shapes on the computer screen.
Eye Tracking Device
Camera aimed at eyes to record eye movements during tasks
OCD Siblings
Healthy controls (HC, n=50) without a family history of OCD will be matched to SIB.
Tasked based functional MRI (fMRI)
2-3 brief computer tasks while brain activity is being measured. The tasks performed will involve making button press responses to letters, numbers or shapes on the computer screen.
Eye Tracking Device
Camera aimed at eyes to record eye movements during tasks
Healthy Controls
Healthy controls (HC, n=50) without a family history of OCD will be matched to SIB.
Tasked based functional MRI (fMRI)
2-3 brief computer tasks while brain activity is being measured. The tasks performed will involve making button press responses to letters, numbers or shapes on the computer screen.
Eye Tracking Device
Camera aimed at eyes to record eye movements during tasks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tasked based functional MRI (fMRI)
2-3 brief computer tasks while brain activity is being measured. The tasks performed will involve making button press responses to letters, numbers or shapes on the computer screen.
Eye Tracking Device
Camera aimed at eyes to record eye movements during tasks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Additional criteria for healthy controls (HC):
* Lifetime absence of major Axis I diagnosis according to Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 criteria
* Not taking psychotropic medications
* No first-degree biological relatives with OCD
Additional criteria for siblings (SIB):
* First-degree biological sibling of a person with OCD
Additional criteria for OCD patients:
* Diagnosis of OCD according to DSM-5 criteria.
Exclusion Criteria
* MRI contraindications such as claustrophobia, ferrous implants, braces, or pacemakers
* Major neurological illness (e.g., self-reported history of organic mental syndromes, head trauma, migraines, seizures, other Central Nervous System (CNS) disease, or other significant medical illness that would make participation unsafe or unfeasible)
* Positive urine toxicology or pregnancy test
* Any disability or health problem that prevents them from completing study procedures (e.g. back problems, severe carpal tunnel syndrome, impaired vision that is not corrected with glasses or contact lenses, etc.).
* Present diagnosis of alcohol use disorder or substance use disorder (moderate or severe)
* Present or previous diagnosis of psychosis, bipolar disorder, or major developmental disorder (autism spectrum disorder, intellectual developmental disorder) based on DSM-5 criteria.
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emily Stern, MD
Role: PRINCIPAL_INVESTIGATOR
NYU Langone Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New York University School of Medicine
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17-01606
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.